General Infectious Disease News Articles

Infectious Dis.

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Jaksch P et al. - A 12-month CMV prophylaxis with oral valganciclovir is effective in significantly reducing CMV viremia and CMV disease/syndrome in high-risk lung transplant recipients. In addition, a reduction in acute and recurrent rejection episodes was observed, possibly due to less CMV viremia and subsequent immunomodulatory effects.


Today in Antimicrobials...keeping you current

Acyclovir: a new use for an old drug
Current Opinion in Infectious Diseases, 10/28/09

Drugs for preventing malaria in travellers
Cochrane Reviews, 10/23/09

Comparison of Gentamicin and Mupirocin in the Prevention of Exit-Site Infection and Peritonitis in Peritoneal Dialysis
Advances in Peritoneal Dialysis, 10/21/09

Today in Other Viral/Bacterial...keeping you current

Hyperbaric oxygen therapy as an anti-infective agent
Expert Review of Anti-infective Therapy, 10/21/09

Focus on Oseltamivir (Tamiflu)
Medicine On-Line, 10/09/09

Influenza A(H1N1)v pandemic in the dialysis population: first wave results from an international survey
Nephrology Dialysis Transplantation, 10/30/09

Today in Surgery/Burn/Transplant...keeping you current

Ulcerative leg nodules in a transplant recipient
Cleveland Clinic Journal of Medicine, 10/16/09

Is use of the hands-free technique during surgery, a safe work practice, associated with safety climate
American Journal of Infection Control, 10/29/09

Comparison of higher dose and lower dose ganciclovir for cytomegalovirus prophylaxis in seropositive heart transplant recipients
Transplant Infectious Disease, 10/16/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address